STOCK TITAN

Vertex Pharmaceuticals (NASDAQ: VRTX) insider files Form 144 to sell vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Vertex Pharmaceuticals submitted a Form 144 notice reporting proposed sales of Common Stock by an insider. The filing lists multiple past transactions in the prior three months and a proposed sale routed through Fidelity Brokerage Services LLC on 05/15/2026. The sales are linked to restricted stock vesting and compensation.

Positive

  • None.

Negative

  • None.

Insights

Form 144 records proposed resale of vested, compensatory common shares.

The filing lists proposed sales and recent dispositions tied to restricted stock vesting and compensation. The filing names Fidelity Brokerage Services LLC as the broker and provides specific transaction dates and dollar amounts for recent sales.

Regulatory focus is procedural: ensure Rule 144 holding-period and manner-of-sale conditions are met; subsequent filings will show completion or further dispositions.

Proposed broker routing date 05/15/2026 Fidelity Brokerage Services LLC routing date shown on the form
Sale reported 05/12/2026 6988 shares, $3,144,600.00 Disposition listed under Securities Sold During The Past 3 Months
Sales reported on other dates 2329 shares, $1,118,641.99 (example) Multiple entries dated 02/27/2026, 03/13/2026, 03/27/2026 showing 2329 and associated dollar figures
Transaction purpose Restricted Stock Vesting / Compensation Form labels linking the sales to compensation-related vesting
Form 144 regulatory
"Form 144 notice reporting proposed sale of securities"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Vesting financial
"Restricted Stock Vesting | Issuer | 02/10/2026"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Compensation financial
"02/10/2026 | Compensation"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Vertex's (VRTX) Form 144 report show?

It reports proposed sales of Common Stock by an insider tied to restricted stock vesting. The filing lists multiple recent dispositions with dates and dollar amounts and a proposed brokerage route through Fidelity Brokerage Services LLC.

Who is identified as the seller in the VRTX Form 144?

The filing lists Carmen R. Bozic as the person associated with recent sales. The record shows her address and multiple transaction dates and amounts in the prior three months linked to compensation or vested restricted stock.

What transaction amounts are disclosed in the filing?

Recent reported sales include entries showing 2329 units with $1,118,641.99, repeated on separate dates, and a 6988 unit sale with $3,144,600.00 on 05/12/2026, as listed in the filing.

Which broker is named for the proposed resale in the filing?

The filing names Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI, as the broker of record for the proposed sale routing noted with a date of 05/15/2026 on the form.